Adagio Therapeutics, Inc.
USD4.64
+0.04 (+0.87%)
IPO Date
2021-08-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.62
Prev. Close
$4.60
Day Low
$4.40
Day High
$4.74
Market Cap
$0.51B
Volume
0.53M
| -0.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -111.9% | -86.7% | 0.01 | 4.47 | -2.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -67.8% | -63.0% | 0.01 | 15.06 | -0.7 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -40.6% | -36.6% | 0.00 | 9.94 | -3.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 171.6% | -95.4% | 0.00 | 8.98 | -20.7 |
| -9.6 |
| 30 Sept 2025 | Q3 | 91.7% | -79.7% | -11.2% | -7.5% | 0.03 | 2.47 | -4.5 |
| 30 Jun 2025 | Q2 | 94.2% | -124.4% | -34.3% | -16.4% | 0.07 | 1.33 | -1.5 |
| 31 Mar 2025 | Q1 | 92.6% | -144.1% | -30.1% | -15.7% | 0.02 | 1.53 | -1.1 |
| 31 Dec 2024 | Q4 | 94.8% | -133.5% | -27.3% | -14.2% | 0.02 | 1.62 | -0.7 |
| 30 Sept 2024 | Q3 | 91.3% | -653.1% | -73.0% | -37.5% | 0.02 | 1.92 | -0.5 |
| 30 Jun 2024 | Q2 | 96.1% | -2086.9% | -33.6% | -26.6% | 0.00 | 4.71 | -0.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -24.4% | -20.2% | 0.01 | 5.77 | -2.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -41.5% | -32.1% | 0.01 | 4.47 | -1.5 |